Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
ZIVO Bioscience, Inc. (ZIVO) had Weighted-Average Shares Outstanding (Diluted) of 3.81M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.05M |
|
$-1.64M |
|
$0.04M |
|
$0.02M |
|
$1.69M |
|
$-1.63M |
|
$-0.01M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.64M |
|
$-1.63M |
|
$-4.17M |
|
3.81M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.81M |
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$0.41M |
|
-- |
|
$0.29M |
|
$0.70M |
|
$2.96M |
|
$0.05M |
|
$0.28M |
|
$3.24M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
3.82M |
|
| Cash Flow Statement Financials | |
$-1.91M |
|
-- |
|
$0.37M |
|
$1.54M |
|
$0.01M |
|
$-1.53M |
|
$0.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-0.02 |
|
-0.02 |
|
33.56% |
|
-3057.81% |
|
-3057.81% |
|
-- |
|
-3071.59% |
|
-3071.59% |
|
$-1.91M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
1.55 |
|
57.92 |
|
64.56% |
|
64.56% |
|
-233.21% |
|
65.77% |
|
$-0.67 |
|
$-0.50 |
|
$-0.50 |
|